Research

rs10786831 — SORCS3 SORCS3 Depression Variant

Intronic variant in the neurotrophin sorting receptor SORCS3, the top GWAS hit for major depression in the Howard et al. 2019 meta-analysis of 807,553 individuals; the G allele impairs glutamate receptor trafficking, fear extinction, and synaptic plasticity

Strong Risk Factor Share

Details

Gene
SORCS3
Chromosome
10
Risk allele
G
Clinical
Risk Factor
Evidence
Strong

Population Frequency

AA
26%
AG
50%
GG
24%

Category

Mood & Behavior

See your personal result for SORCS3

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

SORCS3 — The Synaptic Sorting Receptor at the Heart of Depression Genetics

In 2019, the largest genetic study of depression ever conducted — 807,553 individuals, 246,363 of them with depression — pointed to a single gene more strongly than any other: SORCS311 SORCS3
Sortilin-related VPS10 domain-containing receptor 3 — a member of the VPS10 family of sorting receptors, which guide cargo proteins between cellular compartments in neurons. SORCS3 is expressed predominantly in the brain, where it localizes to the postsynaptic density of glutamatergic synapses.
The rs10786831 variant lies within an intron of SORCS3, in a position that likely influences gene expression rather than protein structure. The G allele at this position is the risk-associated configuration for major depressive disorder, identified with high confidence across multiple independent cohorts.

The Mechanism

SORCS3 is a VPS10-domain receptor22 VPS10-domain receptor
The vacuolar protein sorting 10 (VPS10) domain family sorts cargo between cellular compartments. Members include SORTILIN, SORCS1, SORCS2, and SORCS3. In neurons, these receptors are critical for controlling which proteins reach the synapse, and at what concentrations.
that localizes to the postsynaptic density — the dense protein scaffold that anchors neurotransmitter receptors directly opposite the presynaptic terminal. Its primary job at glutamatergic synapses is to regulate the surface availability of [AMPA receptors | AMPA receptors (AMPARs) are the main mediators of fast excitatory neurotransmission. Their density at the synapse determines how strongly a neuron responds to incoming glutamate signals. Regulated insertion and removal of AMPARs from the postsynaptic membrane is the core mechanism of synaptic plasticity — the cellular basis of learning and memory.], the fast-excitatory receptors that control the amplitude of synaptic responses.

SORCS3 interacts with PICK133 PICK1
Protein interacting with C-kinase 1 — an adaptor protein that mediates AMPA receptor internalization from the postsynaptic membrane. PICK1-SORCS3 interaction is required for normal long-term synaptic depression (LTD), the process of weakening synaptic connections that underlies memory updating and fear extinction.
to orchestrate AMPA receptor internalization. When SORCS3 is absent or reduced in function, PICK1 cannot reach the postsynaptic density properly, AMPA receptors become more mobile and exchange more rapidly at the synapse, and the normal form of synaptic depression is impaired. In parallel, SORCS3 and its relative SORCS1 function as intracellular trafficking receptors for TrkB44 intracellular trafficking receptors for TrkB
TrkB (tropomyosin-related kinase B) is the primary receptor for brain-derived neurotrophic factor (BDNF). When SORCS3 routes TrkB away from the cell surface, it attenuates BDNF signaling. Loss of SORCS3 leaves TrkB unrestrained, potentially dysregulating the neurotrophin response.
— meaning SORCS3 shapes both glutamate receptor dynamics and neurotrophin-receptor signaling simultaneously.

The Evidence

The depression association for rs10786831 rests on two large independent signals. The Hyde et al. 2016 study55 Hyde et al. 2016 study
Identification of 15 genetic loci associated with risk of major depression in individuals of European descent. Nature Genetics 2016.
using 23andMe data (N > 307,000) identified the G allele as the risk configuration (beta = −0.0297, p = 8×10⁻⁹ for the liability scale). The signal was replicated in the Howard et al. 2019 meta-analysis66 Howard et al. 2019 meta-analysis
Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nature Neuroscience, 2019.
covering 807,553 participants, which elevated SORCS3 to the most significant novel gene in the study, with the locus surviving replication in 1,306,354 additional individuals (87 of 102 variants replicated).

The functional evidence from animal models reinforces the genetic signal: SORCS3-knockout mice77 SORCS3-knockout mice
Breiderhoff et al. 2013 — PLoS One; SORCS3-deficient mice show accelerated fear extinction and impaired spatial memory (Barnes maze), while locomotion and initial fear acquisition remain normal. The defect was traced to disrupted PICK1 localization at the postsynaptic density.
display accelerated extinction of fear memory — they lose conditioned fear responses far faster than wild-type controls — and exhibit spatial learning deficits consistent with hippocampal LTD impairment. Electrophysiological recordings from knockout hippocampal slices show a 33% reduction in CA1 synaptic transmission88 33% reduction in CA1 synaptic transmission
Christiansen et al. 2017 — Hippocampus; SorCS3 knockout mice aged P55-65 showed 33% reduction in field EPSPs at CA1 Schaffer collaterals, with enhanced AMPA receptor mobility at the postsynaptic density.
and enhanced AMPA receptor mobility at the postsynaptic density in adult mice — a pattern consistent with impaired ability to consolidate and update emotional memories.

The same rs10786831-A allele (the opposite configuration) is independently associated with insomnia99 insomnia
Watanabe et al. 2022 — Nature Genetics; GWAS of 2.3M individuals identified 554 insomnia loci; rs10786831-A reached p=2×10⁻¹³ (beta=0.007 increase).
at p = 2×10⁻¹³ in a separate GWAS of 2.3 million individuals. This pleiotropic pattern — opposite alleles tagging different disorders — reflects the complex regulatory role of this locus in arousal and emotional memory circuits.

Practical Actions

The actionable insight for G allele carriers centers on supporting synaptic plasticity mechanisms that SORCS3 would normally facilitate: glutamate receptor trafficking, fear extinction circuitry, and neurotrophin signaling. The most evidence-backed behavioral intervention for hippocampal AMPA receptor insertion and LTP induction is aerobic exercise, which also robustly increases hippocampal BDNF. Omega-3 DHA is incorporated into postsynaptic neuronal membranes and is required for optimal AMPA receptor conformation and TrkB signaling. Magnesium is a required cofactor for NMDA receptor function and BDNF synthesis pathways — deficiency amplifies stress reactivity and impairs the very LTD/LTP balance that SORCS3 normally helps calibrate.

Interactions

rs10786831 and the neighboring rs11599236 both lie within SORCS3 intronic regions but tag different GWAS signals — rs11599236 is primarily associated with mood instability, neuroticism, and cross-disorder psychiatric risk, while rs10786831 is the depression-specific lead. Individuals carrying risk alleles at both loci may have compounded effects on neurotrophin trafficking and synaptic depression mechanisms. SORCS3 interacts epistatically with SORCS1 and SORCS2 in the VPS10 receptor family — variants in SORCS1 (rs600879) have been associated with Alzheimer's risk and may compound SORCS3 effects on TrkB trafficking. The SORCS3 gene-set overlaps substantially with synaptic pathways implicated by schizophrenia and bipolar GWAS, making rs10786831 a pleiotropic node at the intersection of depression, fear circuitry, and cognitive plasticity.

Genotype Interpretations

What each possible genotype means for this variant:

AA “Typical SORCS3 Function” Normal

Normal glutamate receptor trafficking and depression risk at this locus

The A allele is the GRCh38 plus-strand reference allele at position chr10:104,854,812. In the Hyde et al. 2016 and Howard et al. 2019 depression GWAS studies, the G allele is the risk-increasing configuration — meaning AA individuals do not carry the genetic risk signal at this SORCS3 locus for major depressive disorder. SORCS3 expression is expected to be at typical levels, maintaining normal PICK1 localization at postsynaptic densities and typical AMPA receptor trafficking dynamics.

The pleiotropic nature of this variant means the A allele carries a weak independent association with insomnia in the Watanabe et al. 2022 GWAS (p=2×10⁻¹³, beta=0.007). However, this effect size is very small and the insomnia phenotype is distinct from the depression mechanism — this is a complex regulatory locus where different directions of effect appear to influence different circuits. The overall classification of AA as the reference/normal genotype for depression is well-supported by the primary literature.

AG “Partial SORCS3 Reduction” Intermediate

One G allele — moderately elevated depression risk from reduced SORCS3 function

SORCS3 encodes a postsynaptic sorting receptor that controls AMPA receptor mobility at glutamatergic synapses by interacting with PICK1, the adaptor protein responsible for receptor internalization. When SORCS3 function is reduced (as the G allele appears to cause), PICK1 cannot efficiently reach the postsynaptic density, AMPA receptors become more mobile, and long-term synaptic depression (LTD) — the cellular mechanism underpinning fear extinction and emotional memory updating — is impaired.

Mouse knockout studies confirmed this mechanism: SORCS3-deficient mice show accelerated fear extinction (losing conditioned fear faster than controls), spatial learning deficits in the Barnes maze, and 33% reduced synaptic transmission in hippocampal CA1 circuits. In human genetics, the G allele's effect is additive: AG carriers sit between AA (typical) and GG (highest risk) for depression liability. Effect sizes per individual GWAS are small — this is a polygenic contributor, not a deterministic mutation — but the signal has replicated across multiple independent cohorts totaling over 800,000 people.

GG “Reduced SORCS3 Expression” High Risk

Two G alleles — highest depression risk at this locus from impaired glutamate receptor trafficking

SORCS3 regulates postsynaptic glutamate receptor dynamics by interacting with PICK1, the adaptor protein that internalizes AMPA receptors during long-term synaptic depression (LTD). LTD in the hippocampus and amygdala underlies fear extinction — the brain's ability to learn that a previously threatening situation is now safe. SORCS3-knockout mice show accelerated fear extinction and spatial learning deficits (Barnes maze), along with a 33% reduction in hippocampal CA1 synaptic transmission — a profile consistent with impaired ability to encode, update, and consolidate emotional memories.

In parallel, SORCS3 and its close relative SORCS1 serve as intracellular trafficking receptors for TrkB (the BDNF receptor), attenuating neurotrophin-receptor signaling. Reduced SORCS3 expression — the direction linked to the G allele based on systematic expression analysis of 46 SORCS3 variants — may therefore dysregulate both glutamate receptor dynamics and BDNF-TrkB signaling simultaneously.

The GG genotype is common in European populations (~24% globally, ~37% in Europeans), meaning this is not a rare risk allele but a common variant contributing modestly to depression liability as part of a polygenic architecture. Environmental factors — particularly chronic stress (which downregulates BDNF), sleep disruption, and inadequate aerobic exercise — substantially modify whether this genetic predisposition translates into clinical depression. The GG genotype is also associated with insomnia risk independently (via the complement A-allele association in the insomnia GWAS), reflecting complex pleiotropic regulation of sleep-mood circuits at this locus.